Showing results (41-50 of 1,172) with videos related to
Sort By:
Pageof 118
Vaccine|January 5, 2000
Cytokine mRNAs in the nasal-associated lymphoid tissue during influenza virus infection and nasal vaccinationK Matsuo, T Iwasaki, H Asanuma, et al.Journal of Immunological Methods|March 28, 1997
Isolation and characterization of mouse nasal-associated lymphoid tissueH Asanuma, A H Thompson, T Iwasaki, et al.The Journal of General Virology|February 24, 1998
Antibody-forming cells in the nasal-associated lymphoid tissue during primary influenza virus infectionS Tamura, T Iwasaki, A H Thompson, et al.Laeknabladid|October 5, 2006
[Attitude of the Icelandic population towards performing cardiopulmonary resuscitation on strangers in the pre-hospital setting.]D O Arnar, S Gizurarson, J BaldurssonThe Journal of Pharmacy and Pharmacology|August 1, 1997
Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbitsE Bechgaard, S Gizurarson, R K HjortkjaerVaccine|February 1, 1997
Intranasal booster vaccination against diphtheria and tetanus in manH Aggerbeck, S Gizurarson, J Wantzin, et al.Vaccine|October 1, 1990
Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenzaS Tamura, H Funato, Y Hirabayashi, et al.Vaccine|March 6, 1999
Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAsZ Chen, K Matsuo, H Asanuma, et al.Pharmaceutical Development and Technology|September 22, 1998
Intranasal vaccination: pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune responsesS Gizurarson, H Aggerbeck, M Gudmundsson, et al.Archives of Virology|June 12, 1999
Exacerbation of influenzavirus pneumonia by intranasal administration of surfactant in a mouse modelT Iwasaki, S Tamura, T Kumasaka, et al.Pageof 118